AAP
SPRY icon

Ardsley Advisory Partners’s ARS Pharmaceuticals SPRY Stock Holding History

Ardsley Advisory Partners’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$8.29M Buy
475,000
+150,000
+46% +$2.62M 1.09% 23
2025
Q1 		$4.09M Buy
+325,000
New +$4.09M 0.78% 44